MST Access

Chris Kallos

Chris Kallos

Life Sciences
Chris Kallos, CFA, is a healthcare and biotech equities analyst with over 20 years experience in both Australian and US stocks. He has covered small, medium and large cap stocks for a range of research houses in Australia, the United Kingdom and the United States. Chris holds a Bachelor of Pharmacy (Sydney), an MBA from the AGSM (UNSW), and a Masters of Applied Finance (Macquarie). He is a CFA charterholder and graduate of the Australian Institute of Company Directors.

Recent Reports

Report Date
Ticker
Company
Sector
Report Name
Apr 01, 2021
RAC.AX
Race Oncology
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Mar 29, 2021
RSH.AX
Respiri Limited
Health Care Equipment & Services
Restricted Offering. Must be a subscriber to view
Mar 11, 2021
CDX.AX
CardieX Limited
Health Care Equipment & Services
Restricted Offering. Must be a subscriber to view
Mar 02, 2021
AVH.AX
AVITA Medical Inc
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Feb 18, 2021
RAC.AX
Race Oncology
Pharmaceuticals, Biotechnology & Life Sciences
Restricted Offering. Must be a subscriber to view
Jan 28, 2021
AVR.AX
Anteris Technologies Limited
Health Care Equipment & Services
Restricted Offering. Must be a subscriber to view

Displaying : of 13 records
1 2 3 > >|

Stock Coverage